Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ACN
3. NVDA
4. MU
5. GOOGL
6. USO
7. APGE
8. ABBV
9. DFTX
10. MSFT

Go back to Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
(NASDAQ: CNTX) Delayed: 0.63 --0 (-0%)
Previous Close $0.63    52 Week High $ 
Open $0.63    52 Week Low $ 
Day High $0.63    P/E N/A 
Day Low $0.63    EPS $ 
Volume 23,892       

(NASDAQ: CNTX) Delayed: 0.63 --0 (-0%)
Previous Close $0.63    52 Week High $ 
Open $0.63    52 Week Low $ 
Day High $0.63    P/E N/A 
Day Low $0.63    EPS $ 
Volume 23,892